These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
458 related articles for article (PubMed ID: 22847613)
1. Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis. Dong P; Karaayvaz M; Jia N; Kaneuchi M; Hamada J; Watari H; Sudo S; Ju J; Sakuragi N Oncogene; 2013 Jul; 32(27):3286-95. PubMed ID: 22847613 [TBL] [Abstract][Full Text] [Related]
2. Mutant p53 induces EZH2 expression and promotes epithelial-mesenchymal transition by disrupting p68-Drosha complex assembly and attenuating miR-26a processing. Jiang FZ; He YY; Wang HH; Zhang HL; Zhang J; Yan XF; Wang XJ; Che Q; Ke JQ; Chen Z; Tong H; Zhang YL; Wang FY; Li YR; Wan XP Oncotarget; 2015 Dec; 6(42):44660-74. PubMed ID: 26587974 [TBL] [Abstract][Full Text] [Related]
3. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC. Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155 [No Abstract] [Full Text] [Related]
4. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1. Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway. Xue M; Pang H; Li X; Li H; Pan J; Chen W Cancer Sci; 2016 Jan; 107(1):18-27. PubMed ID: 26544536 [TBL] [Abstract][Full Text] [Related]
6. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer. Kong X; Ding X; Li X; Gao S; Yang Q Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542 [TBL] [Abstract][Full Text] [Related]
7. The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205. Tran MN; Choi W; Wszolek MF; Navai N; Lee IL; Nitti G; Wen S; Flores ER; Siefker-Radtke A; Czerniak B; Dinney C; Barton M; McConkey DJ J Biol Chem; 2013 Feb; 288(5):3275-88. PubMed ID: 23239884 [TBL] [Abstract][Full Text] [Related]
8. MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1. Yokobori T; Suzuki S; Tanaka N; Inose T; Sohda M; Sano A; Sakai M; Nakajima M; Miyazaki T; Kato H; Kuwano H Cancer Sci; 2013 Jan; 104(1):48-54. PubMed ID: 23013135 [TBL] [Abstract][Full Text] [Related]
9. Inactivation of p53 in pterygium influence miR-200a expression resulting in ZEB1/ZEB2 up-regulation and EMT processing. Wu CW; Peng ML; Yeh KT; Tsai YY; Chiang CC; Cheng YW Exp Eye Res; 2016 May; 146():206-211. PubMed ID: 26995143 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-150 predicts a favorable prognosis in patients with epithelial ovarian cancer, and inhibits cell invasion and metastasis by suppressing transcriptional repressor ZEB1. Jin M; Yang Z; Ye W; Xu H; Hua X PLoS One; 2014; 9(8):e103965. PubMed ID: 25090005 [TBL] [Abstract][Full Text] [Related]
11. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73. Lu Z; Jiao D; Qiao J; Yang S; Yan M; Cui S; Liu Z Mol Cancer; 2015 May; 14():102. PubMed ID: 25972084 [TBL] [Abstract][Full Text] [Related]
12. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2. Qiu G; Lin Y; Zhang H; Wu D Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123 [TBL] [Abstract][Full Text] [Related]
13. miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer. Li BL; Lu C; Lu W; Yang TT; Qu J; Hong X; Wan XP Med Oncol; 2013 Mar; 30(1):484. PubMed ID: 23392577 [TBL] [Abstract][Full Text] [Related]
14. p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. Kim T; Veronese A; Pichiorri F; Lee TJ; Jeon YJ; Volinia S; Pineau P; Marchio A; Palatini J; Suh SS; Alder H; Liu CG; Dejean A; Croce CM J Exp Med; 2011 May; 208(5):875-83. PubMed ID: 21518799 [TBL] [Abstract][Full Text] [Related]
15. miR-1271 inhibits migration, invasion and epithelial-mesenchymal transition by targeting ZEB1 and TWIST1 in pancreatic cancer cells. Liu H; Wang H; Liu X; Yu T Biochem Biophys Res Commun; 2016 Apr; 472(2):346-52. PubMed ID: 26940738 [TBL] [Abstract][Full Text] [Related]
16. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer. Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752 [TBL] [Abstract][Full Text] [Related]
17. Proteasome inhibitor-resistant cells cause EMT-induction via suppression of E-cadherin by miR-200 and ZEB1. Asakura T; Yamaguchi N; Ohkawa K; Yoshida K Int J Oncol; 2015 May; 46(5):2251-60. PubMed ID: 25738863 [TBL] [Abstract][Full Text] [Related]
18. β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness. Sánchez-Tilló E; de Barrios O; Siles L; Cuatrecasas M; Castells A; Postigo A Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19204-9. PubMed ID: 22080605 [TBL] [Abstract][Full Text] [Related]
19. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion. Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]